What's breaking now, across thousands of outlets.
Many dividend investors may be overlooking Pfizer's stock, and that could be a costly mistake.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
O resultado do primeiro turno fez o mercado revisitar suas teses para surfar uma provável mudança no Palácio do Planalto em 2027.
The euro reached a 17-month low against the dollar due to worries over France's budget deficit. Concerns about a potential euro-zone debt crisis have heightened market caution amid political…
The 91-hospital system credited volume gains and greater rates for its 5.2% operating revenue growth and expense management, including a reduction in full-time equivalents and checked cost growth…
Standard Chartered’s Edward Lee expects the Monetary Authority of Singapore (MAS) to deliver another very slight tightening in October, raising the SGD NEER slope to 1.5% from 1.25% while keeping the…
